insights_auto
Why is MEOBF down ၁၃.၄၇%?
Dive Deeperchevron_right
MEOBF:OTCMKTS
Mesoblast Ltd
၁.၃၂ US$
arrow_downward
-၁၃.၄၇%(-၀.၂၁) 1D
အောက် ၁၄, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MEOBF...
Open
၁.၃၂ US$
High
၁.၃၂ US$
Low
၁.၃၂ US$
Mkt. cap
၁၈၂.၅၇ ဋေ
Avg. vol.
၃၉၁.၀၀
Volume
၃၀၀.၀၀
52-wk high
၂.၅၉ US$
52-wk low
၁.၁၄ US$
Beta
၁.၆၈
Shares outstanding
၁၂၉.၈၇ ဋေ
No. of employees
၁၀၈
Open
၁.၃၂ US$
High
၁.၃၂ US$
Low
၁.၃၂ US$
Mkt. cap
၁၈၂.၅၇ ဋေ
Avg. vol.
၃၉၁.၀၀
Volume
၃၀၀.၀၀
52-wk high
၂.၅၉ US$
52-wk low
၁.၁၄ US$
Beta
၁.၆၈
Shares outstanding
၁၂၉.၈၇ ဋေ
No. of employees
၁၀၈
News stories
From web sources and news partners
Kalkine
·
ပြီးခဲ့သည့် ၁၈ နာရီ
Mesoblast Applies to Quote 2,550,000 Ordinary Shares Issued Under Employee Incentive Scheme on 3 September 2026
TipRanks
·
ပြီးခဲ့သည့် ၁ ရက်
Mesoblast Posts First Full-Year Ryoncil Revenue Surge and Files 2026 Annual Report
Stock Titan
·
ပြီးခဲ့သည့် ၁ ရက်
From US$17.2M a year earlier, FY2026 revenue climbs at Mesoblast (MESO).
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd